Michael F Marino Iii Opti Nose, Inc. (OPTN) insider trading activity

Michael F Marino Iii is Chief Legal Officer & Corp Sec of OptiNose, Inc.. Currently has a direct ownership of 0 shares of OPTN, which is worth approximately $0. The most recent transaction as insider was on Sep 20, 2022, when has been sold 1,151 shares (Common Stock) at a price of $3.56 per share, resulting in proceeds of $4,098. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Michael F Marino III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 20 2022	SELL Open market or private sale	$4,098 $3.56 p/Share	1,151 Reduced 0.62%	184,528 Common Stock
Sep 16 2022	SELL Open market or private sale	$5,620 $3.55 p/Share	1,583 Reduced 0.85%	185,679 Common Stock
Sep 15 2022	BUY Grant, award, or other acquisition	-	3,816 Added 2.0%	187,262 Common Stock
Jun 16 2022	SELL Open market or private sale	$37,668 $3.49 p/Share	10,793 Reduced 5.99%	169,286 Common Stock
Jun 15 2022	BUY Grant, award, or other acquisition	-	30,534 Added 14.5%	180,079 Common Stock
Mar 16 2022	SELL Open market or private sale	$9,742 $2.11 p/Share	4,617 Reduced 2.99%	149,545 Common Stock
Jan 11 2022	BUY Grant, award, or other acquisition	-	56,730 Added 26.9%	154,162 Common Stock
Dec 16 2021	SELL Open market or private sale	$951 $1.64 p/Share	580 Reduced 0.59%	97,432 Common Stock
Sep 16 2021	SELL Open market or private sale	$1,613 $2.79 p/Share	578 Reduced 0.59%	98,012 Common Stock
Jun 17 2021	SELL Open market or private sale	$2,148 $3.73 p/Share	576 Reduced 0.58%	98,590 Common Stock
Mar 15 2021	SELL Open market or private sale	$9,032 $3.92 p/Share	2,304 Reduced 2.27%	99,166 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	53,333 Added 42.93%	70,903 Common Stock

Also insider at

NAMS

NewAmsterdam Pharma Co N.V.

MFM